Skip to main content
Equibles

Angela Cacace, Ph.D.

Arvinas, Inc. (ARVN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Arvinas, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARVN alerts

About Angela Cacace, Ph.D.

Angela Cacace, Ph.D. has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Arvinas, Inc. on November 3, 2026. Arvinas, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arvinas, Inc. includes Randy Teel, Ph.D. (CEO and Board Member), Briggs Morrison, M.D. (Chairman), Randy Teel (CFO) and 7 others.

Angela Cacace, Ph.D. on recent calls

“As we approach Keynes Pipeline Milestones, I'll highlight how our preclinical data support our differentiated science, inform clinical development, and position our portfolio to deliver value.”
Other, Arvinas 3Q26 Earnings Call ·
“We've looked across high-grade and low-grade, you know, DLBCL models. We've also looked at AITL, which is nodal T follicular helper of the angioplastic type.”
Other, Wells Fargo 21st Annual Healthcare Conference ·
“I'll begin by talking about the patients with spinal and bulbar muscular atrophy, also known as SBMA or Kennedy's disease. These patients are living with a progressive neuromuscular disorder that steadily robs them of muscle strength and endurance.”
Other, Earnings conference call (announced in 8-K) ·

Affiliation history

Company network

Leadership on record at Arvinas, Inc.

Recent activity